Skip to main content

Post-COVID symptoms in kids puzzle Bengaluru doctors

In yet another discovery about the way in which Covid-19 affects children, doctors in Bengaluru are finding that they sometimes develop certain symptoms nearly a month after they recover from the disease. 

The case of a 9-year-old child brought to Aster CMI Hospital with multi-system inflammatory syndrome (MIS) on Tuesday, 45 days after recovering from Covid-19 took doctors by surprise.  

“We are seeing children come down with MIS, atypical Kawasaki Disease, or toxic shock syndrome, around 30-45 days after getting Covid. MIS is an intense inflammatory reaction to the virus. 

However, we still don’t know why the symptoms appear 30-45 after they recover from Covid-19,” said Dr Srikanta J T, paediatric pulmonology consultant at Aster Hospital. 

Similarly, doctors at Columbia Asia Referral Hospital in Yeshwantpur came across a 12-year-old boy with severe abdominal pain, high fever, high inflammatory markers, chest pain and cardiac changes.

Doctors suspected the symptoms were related to a Covid-19 infection even though like many children, the boy did not display symptoms caused by SARS-CoV-2. An RT-PCR test confirmed their suspicions, and doctors started him on steroids and immunoglobulins, and a week later, he recovered.

“Warning signs that parents must watch out for include high fever, flushed faces, red eyes and lips, swollen hands and feet, tummy issues, abdominal pain, vomiting, breathing difficulty. 

Children can go into a state of shock which means low blood pressure, problems in blood circulation, and cold hands and feet,” said Dr Supraja Chandrashekhar, paediatric intensivist consultant at Columbia Asia.  

The number of cases overall is on the rise and warrants caution, said Dr Jagdish Chinnappa, paediatric consultant at Manipal Hospitals.

“Although post-recovery cases (of such illness) are rare in children, the number will rise as children go outdoors and interact with people. Some children, especially adolescents, may develop respiratory problems and fatigue after recovery. Although MIS is seen only in a small percentage of children, it can affect many parts of the body including the heart and lungs,” he said. 


Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...